MedTrace Logo

Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder

NCT03230682 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2017-07-26

No results posted yet for this study

Summary

Early improvemrnt, decreased 20% in the 17 items of Hamilton Depression Rating Scale (HAMD-17) at the second week of the treatment of major depression disorder (MDD), can arguably predict the remission at the 12th week. Our observation study including 80 MDD patients will access resting-state function MRI to finding factors which infuencing early improvemrnt, respone and remission of antidepressants.

Conditions

Interventions

DRUG

antidepressant

regular one-drups treatment of selective serotonin reuptake inhibitor(SSRIs)

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-25
Primary Completion
2018-06-11
Completion
2018-07-11

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03230682 on ClinicalTrials.gov